HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Parlux to defend before Nasdaq

This article was originally published in The Rose Sheet

Executive Summary

Parlux Fragrances must present before a Nasdaq panel or face delisting of its securities from the market, company announces. After the firm delayed filing its December report with the Securities and Exchange Commission, Nasdaq asked the firm to present an explanation to the Nasdaq Listing Qualifications Panel. Parlux has delayed filings in the past, including its as-yet-unfiled September report. The company is also facing a class action suit, filed Nov. 8, 2006, that consolidates five previously filed class action complaints from August and September 2006. The suit alleges that Parlux "knowingly made false statements about its revenues and profitability beginning on Feb. 8, 2006," and that the company's directors sold company shares "while allegedly in possession of material non-public information." Parlux is currently undergoing investigation by an independent audit committee...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014574

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel